SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-023490
Filing Date
2016-08-09
Accepted
2016-08-09 08:10:57
Documents
5
Period of Report
2016-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 RGNX-8K-20160630 rgnx-8k_20160809.htm 8-K 35897
2 EX-99.1 rgnx-ex991_24.htm EX-99.1 340860
3 EX-99.2 rgnx-ex992_41.htm EX-99.2 13535
4 GRAPHIC gqwjgaauuiai000001.jpg GRAPHIC 3540
5 GRAPHIC g25onxk4v24w000001.jpg GRAPHIC 3540
  Complete submission text file 0001564590-16-023490.txt   401874
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 161816130
SIC: 2836 Biological Products, (No Diagnostic Substances)